Agreement signedPublished 6 Feb 2025

Vincerx /
Oqory

Vincerx Pharma and Oqory Amend Business Combination Terms

Buy side: Vincerx
Buy sideVincerx
Target: Oqory
TargetOqory
Source · 6 Feb 2025Source-verified
Buy side: Vincerx
Buy sideVincerx
Target: Oqory
TargetOqory
01 / BuyerVincerx
02 / TargetOqory
Source-verified
01

What happened

Vincerx Pharma, Inc. and Oqory, Inc. amended their binding term sheet effective Jan. 31, 2025. The amendment raised the minimum value for Vincerx stockholders in the combined company from $13.66 million to $14.16 million and waived the remaining $500,000 of interim financing.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Vincerx Pharma and Oqory Amend Business Combination Terms

This document is the source for the companies, stage, figure and people on this page.

Source-verified
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Also stated

    The source this page is built from.

    Source-verified
  2. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.